|

Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

RECRUITINGN/ASponsored by Changhai Hospital
Actively Recruiting
PhaseN/A
SponsorChanghai Hospital
Started2025-12-01
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06728826

Summary

PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients older than or equal to 18 years of age
* Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries
* Able to provide informed consent

Exclusion Criteria:

* History of atrial fibrillation or flutter
* Reoperations/minimally invasive cardiac surgery/emergent presentation
* Need for hypothermic circulatory arrest
* Disease of the left pleura or previous left thoracotomy
* Chest deformity
* Unlikely to participate in follow-up assessments

Conditions4

Atrial Fibrillation (AF)Cardiac EventsHeart DiseasePericardial Effusion

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.